-
Nature sub-issue: Breakthrough! Sui Jianhua's team at Beijing Institute of Biological Sciences has
Time of Update: 2023-02-03
The results illustrate that the anti-tumor function of S1-F4 is dependent on macrophages and DCs. Further analysis revealed that CD8+ T cells also play an important role in the antitumor effect of S1-F4, and that S1-F4 therapy can induce the generation of antigen-specific long-term immune memory.
-
The pharmaceutical and biological industries have frequently reduced their holdings
Time of Update: 2023-02-03
On January 4, Jichuan Pharmaceutical was reduced by 931,500 shares by Shanghai Stock Connect, and the new holdings were 39,609,300 shares, accounting for 4.
On January 4, Jichuan Pharmaceutical was reduced by 931,500 shares by Shanghai Stock Connect, and the new holdings were 39,609,300 shares, accounting for 4.
-
Announcement of China Biological Fermentation Industry Association on approving and issuing
Time of Update: 2023-02-01
In accordance with the requirements of the "China Biological Fermentation Industry Association Group Standard Revision Work Procedure", the group standard of "Probiotic Products Lactic Acid Bacteria Metabiotics" reviewed and approved by the association is hereby published.
Attachment: List of group standard numbers, names, main contents, etc China Biological Fermentation Industry Association January 9, 2023
-
Issue 12/2018 - Breakthrough in the preparation and application of biological flocculants
Time of Update: 2022-11-14
In addition, the results show that the strain has a high flocculent production capacity when corn alcohol wastewater is used as a substrate, which can not only reduce the production cost of biocoagulant, but also have positive significance for the resource utilization of corn alcohol wastewater.
-
Issue 47/2015 - Cryogenic label products facilitate biological sample collection
Time of Update: 2022-11-13
(Xiaoyun) Human tissue samples require low temperatures during handling, storage, and transportation, which poses significant labeling challenges.
(Xiaoyun) Human tissue samples require low temperatures during handling, storage, and transportation, which poses significant labeling challenges.
-
Issue 49, 2014 - Progress in the preparation of butadiene by pure biological processes
Time of Update: 2022-11-13
(Work) Progress has been made in the preparation of butadiene by purely biological processesGlobal bioenergy companies have announced that they have successfully produced bio-derived butadiene through direct fermentation.
-
Issue 9, 2014 - Breakthrough in the pilot test of succinic acid by biological method
Time of Update: 2022-11-12
(Wang Song) A breakthrough was made in the pilot test of succinic acid by biological methodRecently, Sinopec's major scientific research project, the first domestic biological succinic acid test plant, and the 1000 tons/year succinic acid pilot plant of Yangzi Petrochemical successfully completed the third production test task, and produced high-purity succinic acid products, laying a good foundation for the research and development of the subsequent 10,000-ton process package of the pilot plant.
-
Issue 49, 2013 - China's independent intellectual property rights biological legal polyol PDO project put into production
Time of Update: 2022-11-12
(Xue Jie) China's biological PDO (1,3-propanediol) project with completely independent intellectual property rights has been successfully put into production in Zhangjiagang, and the production line has broken the long-term monopoly of American enterprises in this field.
-
Issue 27/2013 - Green Biologics promotes new bio-based butanol and acetone processes
Time of Update: 2022-11-12
(Xiaohua) Green Biologics promotes new processes for bio-based butanol and acetoneGreen Biologics said today that it has reached an agreement with Easy Energy Systems to retrofit Easy Energy's ethanol demonstration plant in Emitsburg, Iowa.
-
BSI Issued ISO 14001 and ISO 45001 International Standard Certificates to WuXi Biologics in Suzhou
Time of Update: 2022-08-20
Suzhou WuXi Biologics was awarded ISO 14001 and ISO 45001 international standard certification by BSI Cai Hui, head of Suzhou WuXi Biologics Base , said, first of all, congratulations to the factory for successfully passing the audit and obtaining the certificate.
-
CDE Announcement on Issuing the "General Format and Guidelines for Writing Instructions
Time of Update: 2022-08-11
Notice of the Center for Drug Evaluation of the State Food and Drug Administration on Issuing the "General Format and Writing Guidelines for the Instructions of Chemical Drugs and Biological Products
-
9 pharmaceutical and biological companies issued repurchase plans, most of which exceeded 100 million yuan
Time of Update: 2022-05-02
Tigermed announced on the evening of February 14 that the company plans to use its own funds or self-raised funds to repurchase some of the company's A shares through centralized bidding transactions, with a repurchase amount of not less than 250 million yuan and not more than 50 million yuan.
-
The National Medical Insurance Administration issued a document in response to promoting the inclusion of biological drugs in centralized procurement
Time of Update: 2021-08-26
The Ministry of Finance coordinated to guide and supervise the implementation of the policy for the retention of medical insurance funds in the centralized procurement of drugs organized by the state .
-
Boan Biological publishes the research results of the new crown neutralizing antibody in a sub-issue of the journal Nature
Time of Update: 2021-07-08
LY-CovMab is a recombinant fully human monoclonal neutralizing antibody that specifically binds to the receptor domain (RBD) of the spike protein on the surface of SARS-CoV-2 with high affinity, and can effectively block the surface of the virus and host cells.
-
The FDA issues guidelines for biologics for 2021
Time of Update: 2021-03-08
CBER said it plans to complete guidance this year on interpreting gene therapy drug similarity in accordance with orphan drug regulations and update its small business compliance guidelines for human cells, tissues and cell-based and tissue-based products (HCT/Ps).
